Aberrant expression of caspase-14 in epithelial tumors

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Death Mechanisms

Background:

• Caspases are key regulators of apoptosis.
• Caspase-14 is a divergent mammalian caspase with unique expression and processing patterns.
• Typically, caspase-14 is not processed during apoptosis but is cleaved during terminal differentiation in skin.

Purpose of the Study:

• To investigate the expression and processing of caspase-14 in human carcinomas.
• To determine if caspase-14 is mutated or alternatively spliced in tumors.
• To understand the potential role of caspase-14 re-expression in cancer development.

Main Methods:

• Immunohistochemistry was used to detect caspase-14 expression in lung squamous cell carcinomas, breast cancers, and cervical carcinomas.
• Analysis included assessment of caspase-14 localization relative to differentiation markers and necrotic areas.
• Tumor samples were analyzed for mutations and alternative splicing of the caspase-14 gene.

Main Results:

• Caspase-14 was expressed in 40% of lung squamous cell carcinomas, 22% of breast cancers, and 80% of cervical carcinomas.
• Expression was observed in areas of differentiation near necrotic sites, but not strictly correlated with keratin-1/-10.
• Caspase-14 was not found to be mutated or alternatively spliced and remained unprocessed in the analyzed tumors.

Conclusions:

• The gene for caspase-14, normally silent in many tissues, is re-expressed in specific tumor types.
• The lack of processing suggests a non-canonical function for caspase-14 in the tumor microenvironment.
• These findings indicate a potential role for caspase-14 in tumorigenesis, distinct from its known functions in apoptosis and differentiation.